Skip to content

8-KAccepted Oct 16, 5:00 PM ET

TuHURA Biosciences: borrows $650,000 under $50,000,000 revolver

HURATuHURA Biosciences, Inc./NV

Accepted (ET)

5:00 PM

Oct 16, 2026

Filed

Oct 16, 2026

Documents

9

Size

170.0 KB

Summary

TuHURA Biosciences: borrows $650,000 under $50,000,000 revolver

Updated

What happened The filing says that on Apr 21, 2026 the Company entered into a Loan Agreement with Parkview Holdings One LLC providing a revolving credit facility with maximum availability of $50,000,000 that matures Apr 21, 2031. The filing says the Company received and borrowed an additional draw under the revolving credit facility in the amount $650,000 on Oct 9, 2026 and expects to use the funds for general corporate purposes.

Key details

  • lender: Parkview Holdings One LLC.
  • original Loan Agreement date: Apr 21, 2026.
  • facility maximum availability: $50,000,000.
  • additional draw amount borrowed: $650,000 on Oct 9, 2026.
  • stated use of funds: general corporate purposes.
  • the Loan Agreement copy was filed as Exhibit 4.1 to the Company’s Form 8-K filed Apr 22, 2026.

Why it may matter The filing reports Item 2.03: creation of a direct financial obligation, which covers the Company’s borrowing activity under the described revolving credit facility and the terms noted above. A filing does not show why the insider traded or why the company acted.

AI-written summary · check the filing